Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Corrigendum: X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.

Rand D, Derdak Z, Carlson R, Wands JR, Rose-Petruck C.

Sci Rep. 2016 Mar 10;6:21229. doi: 10.1038/srep21229. No abstract available.

2.

X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.

Rand D, Derdak Z, Carlson R, Wands JR, Rose-Petruck C.

Sci Rep. 2015 Oct 29;5:15673. doi: 10.1038/srep15673. Erratum in: Sci Rep. 2016;6:21229.

3.

Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.

Huang CK, Yu T, de la Monte SM, Wands JR, Derdak Z, Kim M.

J Hepatol. 2015 Jul;63(1):191-8. doi: 10.1016/j.jhep.2015.02.030. Epub 2015 Feb 24.

4.

A highly sensitive x-ray imaging modality for hepatocellular carcinoma detection in vitro.

Rand D, Walsh EG, Derdak Z, Wands JR, Rose-Petruck C.

Phys Med Biol. 2015 Jan 21;60(2):769-84. doi: 10.1088/0031-9155/60/2/769. Epub 2015 Jan 5.

5.

Obesity-associated mechanisms of hepatocarcinogenesis.

Karagozian R, Derdák Z, Baffy G.

Metabolism. 2014 May;63(5):607-17. doi: 10.1016/j.metabol.2014.01.011. Epub 2014 Feb 5. Review.

PMID:
24629562
6.

Strain-dependent differences for suppression of insulin-stimulated glucose uptake in skeletal and cardiac muscle by ethanol.

Lang CH, Derdak Z, Wands JR.

Alcohol Clin Exp Res. 2014 Apr;38(4):897-910. doi: 10.1111/acer.12343. Epub 2014 Jan 24.

7.

Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR.

J Hepatol. 2013 Apr;58(4):785-91. doi: 10.1016/j.jhep.2012.11.042. Epub 2012 Dec 2.

8.

Alcohol, insulin resistance and the liver-brain axis.

de la Monte S, Derdak Z, Wands JR.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:33-41. doi: 10.1111/j.1440-1746.2011.07023.x. Review.

9.

Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats.

Derdak Z, Villegas KA, Wands JR.

Liver Int. 2012 May;32(5):761-70. doi: 10.1111/j.1478-3231.2012.02752.x. Epub 2012 Jan 31.

PMID:
22292946
10.

Mitochondrial recoupling: a novel therapeutic strategy for cancer?

Baffy G, Derdak Z, Robson SC.

Br J Cancer. 2011 Aug 9;105(4):469-74. doi: 10.1038/bjc.2011.245. Epub 2011 Jun 28. Review.

11.

Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma.

Rand D, Ortiz V, Liu Y, Derdak Z, Wands JR, Tatíček M, Rose-Petruck C.

Nano Lett. 2011 Jul 13;11(7):2678-83. doi: 10.1021/nl200858y. Epub 2011 Jun 6.

12.

Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.

Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, de la Monte SM, Wands JR.

J Hepatol. 2011 Jan;54(1):164-72. doi: 10.1016/j.jhep.2010.08.007. Epub 2010 Sep 6.

13.

Detection of uncoupling protein-2 (UCP2) as a mitochondrial modulator of apoptosis.

Derdak Z, Garcia TA, Baffy G.

Methods Mol Biol. 2009;559:205-17. doi: 10.1007/978-1-60327-017-5_15.

PMID:
19609759
14.

Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.

Harangi M, Mirdamadi HZ, Seres I, Sztanek F, Molnár M, Kassai A, Derdák Z, Illyés L, Paragh G.

Transl Res. 2009 Apr;153(4):190-8. doi: 10.1016/j.trsl.2009.01.007. Epub 2009 Feb 14.

PMID:
19304278
15.

Low density contrast agents for x-ray phase contrast imaging: the use of ambient air for x-ray angiography of excised murine liver tissue.

Laperle CM, Hamilton TJ, Wintermeyer P, Walker EJ, Shi D, Anastasio MA, Derdak Z, Wands JR, Diebold G, Rose-Petruck C.

Phys Med Biol. 2008 Dec 7;53(23):6911-23. doi: 10.1088/0031-9155/53/23/017. Epub 2008 Nov 12.

PMID:
19001700
16.

The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.

Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G.

Br J Clin Pharmacol. 2008 Sep;66(3):366-74. doi: 10.1111/j.1365-2125.2008.03213.x.

17.

The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells.

Derdak Z, Mark NM, Beldi G, Robson SC, Wands JR, Baffy G.

Cancer Res. 2008 Apr 15;68(8):2813-9. doi: 10.1158/0008-5472.CAN-08-0053.

18.

Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice.

Sheets AR, Fülöp P, Derdák Z, Kassai A, Sabo E, Mark NM, Paragh G, Wands JR, Baffy G.

Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G1017-24. doi: 10.1152/ajpgi.00016.2008. Epub 2008 Feb 21.

19.

Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression.

Fülöp P, Derdák Z, Sheets A, Sabo E, Berthiaume EP, Resnick MB, Wands JR, Paragh G, Baffy G.

Hepatology. 2006 Sep;44(3):592-601.

PMID:
16941708
20.

Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress.

Derdák Z, Fülöp P, Sabo E, Tavares R, Berthiaume EP, Resnick MB, Paragh G, Wands JR, Baffy G.

Carcinogenesis. 2006 May;27(5):956-61. Epub 2006 Jan 9.

PMID:
16401637
21.

Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice.

Horimoto M, Fülöp P, Derdák Z, Wands JR, Baffy G.

Hepatology. 2004 Feb;39(2):386-92.

PMID:
14767991

Supplemental Content

Loading ...
Support Center